🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Robyn J. Hylind

Ultragenyx Pharmaceutical (United States)

ORCID: 0000-0002-8280-4541

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Benefits, harms, and costs of newborn genetic screening for hypertrophic cardiomyopathy: Estimates from the PreEMPT model”.

Benefits, harms, and costs of newborn genetic screening for hypertrophic cardiomyopathy: Estimates from the PreEMPT model

Genetics in Medicine(2023)10.1016/j.gim.2023.100797

N/A

0DataRank · unranked

7 citations

Pamela M. McMahon, Lauren N. Galbraith, Jennifer M. Yeh, Natasha K. Stout, Christine Y. Lu +5 more

Clinical features and outcomes in carriers of pathogenic desmoplakin variants

European Heart Journal(2024)10.1093/eurheartj/ehae571

N/A

0DataRank · unranked

70 citations

Richard Carrick, Alexandros Protonotarios, Brittney Murray, Mikaël Laredo, Iris van der Schaaf +56 more

A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers

European Heart Journal(2024)10.1093/eurheartj/ehae409

N/A

0DataRank · unranked

60 citations

Alessio Gasperetti, Alexandros Protonotarios, Brittney Murray, Mikaël Laredo, Iris van der Schaaf +57 more

Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

JACC Advances(2024)10.1016/j.jacadv.2024.100832

N/A

0DataRank · unranked

41 citations

Richard Carrick, Alexandros Protonotarios, Mikaël Laredo, Iris van der Schaaf, Petros Syrris +41 more